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Absract:
The  purpose  of  this  study  was  to  determine  how  the  health-related  quality  of  life  (HRQoL)  of
patients  with  prostate  cancer  and  their  spouses  change  during  the  6  months  after  diagnosis  and
which factors explain the changes. Patients with prostate cancer and their spouses have reported a
decrease in HRQoL, but simultaneous follow-up of the HRQoL of patients with prostate cancer and
their spouses is rare. The sample consisted of 186 couples. The participants personally filled in the
RAND-36-Item Health Survey, both at the time of diagnosis and 6 months later. Changes in the
HRQoL were analysed statistically using descriptive statistics and non-parametric tests. Linear
regression models were used to identify the factors associated with the changes in HRQoL in the
patients  and  their  spouses.  The  HRQoL of  patients  with  prostate  cancer  and  their  spouses  did  not
change significantly during the first 6 months after diagnosis. Changes in the patients’ bodily pain
and physical functioning were explained by their background variables. The spouses’ background
variables did not explain the changes in HRQoL during the follow-up period. In addition, the
changes in the HRQoL of patients and their spouses are very similar. There is a need for long-term
assessment of changes in the HRQoL of patients with prostate cancer and their spouses. The
findings indicate that attention should be paid to spouses with regard to the nursing of patients with
prostate cancer, as spouses seem to be an important resource for patients with prostate cancer.
Funding / Competing interests: The authors declare no conflict of interest.
Key words: Health-related quality of life, Longitudinal study, Nursing Research, Patients with
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Background for the study
The incidence of prostate cancer has been rapidly increasing in parts of the developing world, and it
is currently the most common non-cutaneous cancer in men (Torre et al. 2015). The causative
factors of prostate cancer remain unclear (Ferlay et al. 2015). The known risk factors are age, race
and familial predisposition (Crawford 2009). Annually, over 4700 Finnish men are diagnosed with
prostate cancer, 80% of whom live with their spouses (Lehto et al. 2015, Engholm et al. 2015).
Several treatment options are available for prostate cancer, and the treatment decisions are made
jointly  by  the  physician  and  the  patient  during  treatment  visits  (Heidenreich  et  al.  2011).  Each
treatment option might be associated with persistent or transient side effects such as hormonal,
sexual, urinary and bowel symptoms; emotional distress and general symptoms; fatigue, pain and
sleep disturbance (Heidenreich et al. 2011). These side effects have been shown to decrease the
quality  of  life  (QoL)  of  patients  and  also  negatively  affect  the  QoL  of  their  spouses  (Song  et  al.
2015, Song et al. 2011).
Health-related of quality of life (HRQoL) can be defined in many ways, and it is composed of
physical, psychological, social and emotional functional domains. It is also considered to be a
person’s subjective and individual assessment of his or her situation. In addition, individual values
and cultural context also affect HRQoL (Albaugh and Hacker 2008, Ferrans et al. 2005, Ware and
Sherbourne 1992). Several studies have established that cancer and its treatment can have a
significant effect on the QoL of both people with cancer and their family members (Hawkins et al.
2009, Hodges et al. 2005, Resnick et al. 2013, Kornblith et al. 1994). In particular, the distress level
of male patients is most closely associated with that of their female carers (Hodges et al. 2005).
Moreover, research has shown that spouses’ beliefs about their partner’s illness influence the beliefs
related to QOL in patients with prostate cancer (Wu et al. 2013).
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The QoL of patients with prostate cancer has been studied from the perspective of treatment
methods in the long term. Three to four years after radical prostatectomy or radical external beam
radiation therapy, affected men found that their QoL had decreased, particularly in the sexual
domain, according to measurements with a disease-specific instrument; however, no differences
were found between the treatment methods, according to the measurements of a general instrument
(Nicolaisen et al. 2014). In another study, over a four-year follow-up period, the patients who were
in the watchful waiting group reported lower QoL than those who underwent conventional or low-
dose mixed-beam radiation treatment (Galbraith et al. 2005). However, three of the eight QoL
dimensions—physical functioning, vitality and general health—significantly declined during the
follow-up period (Galbraith et al. 2005). Watchful waiting is a prostate cancer management option
for older men with well-differentiated low-volume prostate cancer and a life expectancy of less than
10 years (Wallace et al. 2004). Although there are studies on the HRQoL of patients with prostate
cancer, the HRQoL of the spouses of these patients has not received much attention in studies. In
one such study, Harden et al. (2013) have reported that younger (<65 years) spouses had lower QoL
than older spouses two years after prostate cancer treatment.
Changes in QoL have been reported over short follow-up periods too. For example, in one study,
six months after prostate cancer treatment, no significant differences were observed in the eight
dimensions of QoL between patients who had undergone surgery and brachytherapy (Hashine et al.
2009). Further, patients with prostate cancer who were treated with hormonal treatment and
radiation therapy reported that their physical function significantly decreased at six months
(Paterson et al. 2015). However, there were no significant changes in the other dimensions of QoL
(Paterson  et  al.  2015).  Similar  results  have  been  reported  by  Ward-Smith  and  Kapitan  (2005)  in
patients with prostate cancer who underwent external beam radiation therapy. However, the
negative changes in the social dimension of QoL appeared within three months after treatment
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(War-Smith and Kapitan 2005.) Previous studies have shown associations between QoL and
background variables. For example, in a longitudinal, randomized clinical trial study, better QOL
was associated with lower education level of the patients, older age of their partners, higher family
income and localized cancer at the baseline (Song et al. 2011). Further, the QoL of patients and
their partners was moderately correlated with each other (Song et al. 2011).
Although there is much information about HRQoL in patients with prostate cancer, little is known
about their spouses’ perspectives on HRQoL. Simultaneous follow-up of patients and their spouses
is worthy of investigation, as this information will help identify the needs of patients and their
spouses and develop evidence-based interventions for patients with prostate cancer and their
spouses.
6	
	
Research questions
The  aim  of  this  study  was  to  monitor  changes  in  HRQoL  and  identify  the  associated  factors  in
patients with prostate cancer and their spouses. The following research questions were set:
1. How does the HRQoL of patients with prostate cancer and their spouses change during the
six months after diagnosis of prostate cancer?
2. Which factors are associated with changes in the HRQoL of patients with prostate cancer
and their spouses during the six-month follow-up period?
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Sample
Study Design and Participants
The data for this longitudinal study were collected using questionnaires administered to patients
with  prostate  cancer  (N=  350)  and  their  spouses  (N=  350)  at  the  time  of  diagnosis  and  the  six–
month period that followed. At the time of diagnosis, all patients were aware of the prostate cancer,
but the treatment did not have an effect on their HRQoL. At the timepoint of six months, the
invasive treatments were finished in all patients and the recovery time had begun. The selection of
timepoints is also supported by previous literature (Street et al 2010, Paterson et al 2015). The data
were analyzed using a paired-samples t-test, based on the assumption that a ten-point change in
HRQoL is clinically significant (Osoba et al. 2005). Based on the sample calculation method
recommended by Osoba et al. (2005) to achieve a power of 0.8 with a standard deviation of 20 and
an  alpha  value  of  0.05,  a  total  of  33  participants  are  required.  Thus,  the  target  number  of
participants for this study was 33. Because there was more than one point of measurement, at least
four types of treatment and five different hospitals, the questionnaire was distributed to 350 couples.
The original power calculation was performed as described above. In practice, it was found that the
changes were smaller than expected, so the original plan of analyzing hospitals separately was
rejected. The local ethics committee approved of the study design. Permission for conducting the
study was obtained from the directors of the five participating hospitals. All participants were
informed  of  the  purpose  of  the  study,  the  longitudinal  research  design  and  the  principle  of
voluntary, anonymous participation.
The data for the first stage were collected between October 2013 and January 2016 at the outpatient
urology clinics of five Finnish central hospitals. The nurses asked patients with prostate cancer who
wished to participate for their written informed consent during their treatment visits. The study
included (1) patients diagnosed with prostate cancer who were at the pre-treatment stage, (2)
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patients who described their relationship with their spouse as being permanent, and (3) patients who
provided their written informed consent and additional contact information for their spouses. All
treatment modalities were included in the study. Each patient was asked to provide the name of
their spouse. If a patient agreed to participate in the study, he was given a letter containing the
required information with the questionnaire and an envelope addressed to himself and his spouse.
The questionnaires were returned by 232 patients and 229 spouses. No follow-up reminder was sent
to the participants out of respect for their autonomy. In the second stage, questionnaires were sent to
patients or spouses who had answered the questionnaires in the first stage and were willing to
continue with the study. The data for the second stage were collected between April 2014 and July
2016 from patients (n = 199) and their spouses (n = 195). Only the data of couples (n = 186) who
participated in the study at both measuring points were included in the analysis. The study samples
are presented in Table 1.
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Data collection methods
Data related to the patients’ and their spouses’ HRQoL were collected with the help of identical
questionnaires. The general HRQoL instrument was chosen to measure HRQoL so that it was easy
to  compare  the  HRQoL of  patients  and  their  spouses.  The  RAND 36-item health  survey  (RAND-
36) was used to measure HRQoL based on eight separate dimensions: physical functioning, role
functioning/physical, role functioning/emotional, energy, emotional well-being, social functioning,
bodily pain and general health (Aalto et al. 1999, Ware and Sherbourne 1992). The Finnish version
of  RAND-36  (Aalto  et  al.  1999)  contains  exactly  the  same  questions  as  MOS  SF-36  (Ware  and
Sherbourne 1992) but the scoring system for bodily pain and the general health scales differs
slightly  (Aalto  et  al.  1999).  The  items  were  scored  on  a  2-  to  6-point  Likert-type  scales.  Each
dimension of HRQoL is separately scored from 0 to 100, where a higher score indicates a better
HRQoL. MOS SF-36 is an internationally known, validated and used instrument for measuring
HRQoL in prostate cancer patients (Dieperink et al. 2012, Treiyer et al. 2011) and their spouses
(Harden et al. 2013). The reliability and construct validity of RAND-36 as a measure of HRQoL in
the Finnish general population (Aalto et al. 1999) and Finnish patients with prostate cancer and their
spouses have been found to be good (Vasarainen et al. 2013, Authors 2017).
The demographic background characteristics include self-reported age, duration of marital
relationship, basic and vocational education, employment status and chronic diseases. In addition to
these questions, the patients were asked about the hospital where the cancer was treated and the
treatment methods for prostate cancer. The treatment methods were divided into four groups:
surgery (all forms of radical prostatectomy), radiation therapy (brachytherapy and external beam
radiation), hormonal treatment and non-invasive care (active and passive follow-up care).
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Data analysis
Data were described using frequencies, percentages, means and standard deviations. The RAND-36
items were scored in accordance with the manual (Aalto et al. 1999). The resulting subscale scores
were on a 0–100 scale, with higher values representing a better HRQoL. Differences between
patients and their spouses with regard to changes in HRQoL were analyzed using the Wilcoxon
signed-rank test because the distribution was skewed. A ten-point change was considered to be
clinically significant on the RAND-36 scale (Aalto et al. 1999, Osoba et al. 2005) The patients and
their spouses were divided into three groups: those in whom the HRQoL increased by ten or more
points, those in whom the HRQoL decreased by ten points or more, and those in whom the HRQoL
did not change. Cross-tabulations with the χ2 test and ANOVA were used for testing dependencies
between grouped HRQoL and background variables. Linear regression models were used to identify
the factors associated with the changes in HRQoL in the patients and their spouses (Munro 2005).
The residuals were examined and considered to be normally distributed (Munro 2005). Models were
created separately for the patients and their spouses. The IBM SPSS statistics version 23 (IBM
Corp., Armonk, NY, USA) was used to analyze the data. The level of statistical significance was set
at P < 0.05.
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Results
Demographic characteristics of the sample
Table 2 describes the demographic characteristics of patients with prostate cancer and their spouses
six months after diagnosis. The mean age of the patients was 68 years (±8.1). The spouses were on
average 3 years younger (65 ± 8.4 years). The respondents’ marital relationship had been ongoing
for an average of 36 years (±15.4, range: 1–60 years). Two-thirds of the patients and nearly half of
the spouses had finished elementary school or civic school. More than one-third of the patients and
their spouses had initial vocational qualifications. More than two-thirds of the respondents were not
employed. Chronic disease, such as cardiovascular diseases, diabetes, chronic lung diseases and
musculoskeletal disorders, was reported by 70% of the 186 patients and 66% of the 186 spouses.
More than one-third of the patients had undergone surgical treatment for their prostate cancer; less
than a third had undergone radiation therapy; less than a fourth had undergone non-invasive care;
and 13% had undergone hormonal treatment during the follow-up period.
Changes in HRQoL in the patients and their spouses within six months
The mean HRQoL scores at the time of diagnosis and six months after diagnosis are presented in
Table 3. On average, the HRQoL of the patients with prostate cancer and their spouses did not
change significantly over the six-month study period. The data for participants for whom the
HRQoL changed by ten points or more on the RAND-36 scale have also been described in Table 3.
More than one-fifth of the patients and their spouses reported at least a ten-point increase or
decrease during the six-month study period. The changes were very similar in patients and their
spouses. Statistically significant differences were not observed between the groups.
Factors associated with changes in HRQoL in the patients and their spouses
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Patients’ age, basic education, vocational qualifications, employment status, chronic diseases and
treatment method for prostate cancer explained 13.1% of the variance in bodily pain (Table 4.). The
background variables did not significantly explain the variance in the other dimensions of the
patients’ HRQoL. Six months after prostate cancer diagnosis, basic education explained 4% of the
variance in physical functioning. The patients who had higher basic education presented with a
greater change in physical functioning (Table 4). Only the statistically significant results have been
reported in Table 4.
Six months after prostate cancer was diagnosed, the background variables of the spouses did not
significantly  explain  the  variance  of  the  dimensions  of  the  spouses’  HRQoL.  The  spouses’
background variables did not explain the changes in the patients’ HRQoL in a statistically
significantly way, and vice versa (data are not shown in a table).
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Conclusions, implications for practice
This study examined changes in the HRQoL of patients with prostate cancer and their spouses at the
time of diagnosis and six months later. The study also identified the factors associated with changes
in  the  HRQoL  of  participants.  Our  main  finding  was  that  the  HRQoL  of  patients  with  prostate
cancer and their spouses did not change significantly during the follow-up period. Nonetheless, the
changes observed in the HRQoL of the patients were explained by their background variables.
A surprising discovery in this study was that that  the changes in the HRQoL of patients and their
spouses six months after prostate cancer diagnosis were on average minor. One of the reasons may
be that the HRQoL of the patients and their spouses at the time of diagnosis was already high. On
the other hand, one could assume that the side effects of treatments, such as surgery and radiation
therapy, would show up at six months after diagnosis. In addition, the instrument used may have
had some effect on the results of HRQoL. QoL is generally measured using both disease-specific
instruments and generic instruments. A study by Paterson et al (2015) found that the HRQoL of
patients with prostate cancer significantly decreased, according to a prostate cancer-specific
instrument, at the six-month follow-up. However, although this study included all the treatment
modalities, information about the marital relationship of the patients was not reported (Paterson et
al. 2015). In a similar study, War-Smith and Kapitan (2005) also showed that the physical and
social well-being of patients changed significantly after external beam radiation therapy, according
to a disease-specific instrument. In contrast to these findings, Harden et al. (2013) reported that the
QoL  of  spouses  was  generally  good  with  a  generic  QoL  instrument  in  a  longitudinal,  two-year
follow-up study. In our study, the participants were in a long-term marital relationship, which may
explain the high HRQoL. However,  it  is  difficult  to confirm such an effect,  as the significance of
marital relationship in the HRQoL of patients with prostate cancer and their spouses is not clearly
understood.
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According to the results of this study, the HRQoL of the patients had decreased with regard to six
dimensions of HRQoL (physical functioning, physical/emotional role functioning, energy, social
functioning and general health). In contrast, the HRQoL of their spouses had reduced for the
following four dimensions: physical functioning, physical role functioning, bodily pain, and general
health dimensions. Previous research has also found that patients with prostate cancer show
negative changes with regard to the social and physical dimensions of HRQoL after prostate cancer
diagnosis and treatment (War-Smith and Kapitan 2005, Galbraith et  al.  2005) The findings from a
follow-up study (Segrin et al. 2012) show that the spouses’ psychological QoL at four months after
treatment was predictive of the patients’ psychological QoL at six months after treatment. We have
not found similar associations in our study, but Segrin and colleagues (2012) used a prostate-
specific instrument for HRQoL and we used a general HRQoL instrument, so this may explain the
difference in the findings. The decrease in the physical dimension score of HRQoL in our study
could be explained by the age of the participants. The decrease in the physical dimension score may
also have been caused by the prostate cancer treatment itself. In a randomized, controlled trial study
of primary prostate cancer patients, intervention was observed to be beneficial in improving the
physical QoL (Dieperink et al. 2013). Another factor that affects HRQoL may be how patients and
their spouses deal with the illness. Recent empirical evidence indicated that at the time of diagnosis,
the spouses of patients with prostate cancer were more socially active than the men, but three and
twelve months later, their involvement in social activities was more similar (Ezer et al. 2011). Our
results followed a similar trend, as the decrease in social functioning of the patient corresponded to
an increase in their spouses’ social functioning during the follow-up period; however, the changes
were not statistically significant.
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Findings from this study show that the background variables of the patients with prostate cancer
(age, basic education, vocational qualifications, employment status, chronic diseases and treatment
method)  explained  some  of  the  changes  in  bodily  pain  and  physical  functioning.  According  to  a
previous study (Song et al. 2011), patients and partners with a lower education level, older age,
higher family income and localized cancer at the baseline were associated with better QoL. The
findings of the present study also indicate the effect of age on changes in physical functioning.
Moreover, in our study, the treatment method may have also partly influenced the changes in the
bodily pain scores of the patients. Street et al. (2010) reported in a semi-structured qualitative study
that a fifth of the spouses assessed themselves to be distressed, and that at six months after prostate
cancer treatment, the majority of spouses reported that they had emotionally adapted and were not
distressed anymore. With regard to our study, the six-month period following prostate cancer
diagnosis may have been too short a time to discover the changes in HRQoL.
Strengths and Limitations
This study has some limitations. First, confounding factors such as family relationships or economic
status might have affected the results. Furthermore, the patients were not asked about their first
symptom of prostate cancer or the degree of the cancer. Second, the sample could have been
selective, and there is a possibility that the study only included participants who felt that their
HRQoL was better who non-responded. Third, the use of one QOL scale simplifies the complex
concept of QoL. However, RAND-36 was chosen so as to allow for comparisons with spouses.
Even  though the  sample  size  was  quite  small,  the  strength  of  this  study  is  that  the  HRQoL of  the
same patients and their spouses was followed up at two different stages of the prostate cancer. The
response rate was also excellent, especially at the second measurement point. On the other hand,
this may have caused a bias, too, because it is probable that it was the participants who felt that their
HRQoL was better who responded to the second survey. On the other hand, the non-response
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analysis demonstrated that the demographic characteristics of the non-responders did not differ
from that of the respondents in the second stage.
Implications for Practice
The present study findings indicate that in the case of patients with prostate cancer, care should be
extended to their spouses as well. In practice, this means that healthcare professionals should pay
attention to the spouses of patients, and that the spouses should be encouraged to participate
actively in the care of patients with prostate cancer. The information presented in this study can
help nurses plan the care of patients with prostate cancer from the perspective of the couples. Future
research should use a longer follow-up period to study the changes in the HRQoL of patients with
prostate cancer and their spouses, in addition to the factors associated with changes in HRQoL.
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WHAT IS KNOWN ABOUT THIS TOPIC
Prostate cancer and side effects of treatments have been shown to decrease the quality of life of
patients and also negatively affect the QoL of their spouses. Simultaneous follow-up of patients and
their spouses is worthy of investigation.
WHAT THIS PAPER ADDS
The findings from this study add knowledge about the HRQoL of patients with prostate cancer and
their spouses over a six-month follow-up period. Our results show that the HRQoL of patients with
prostate cancer and their spouses did not change, on average, during the six months after diagnosis.
Although there was some variation in individual HRQoL scores, this variation was quite similar
17	
	
between the patients and their spouses. The background variables of the patients with prostate
cancer explained the changes in bodily pain scores, and their basic education level explained the
changes in the physical functioning scores.
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Table 1. Response rates of the study participants at the time of diagnosis and six months later
Patient Spouse
Time n response rate n response rate
At the time of diagnosis
Number of questionnaires sent 350 350
Number of returned questionnaires 234 67% 230 66%
Number of rejected questionnaires 2 1
Number of samples analyzed 232 229
Number of respondents who did not
continue with the study
1 1
Six months
Number of questionnaires sent 231 228
Number of returned questionnaires 199 86% 195 86%
Number of questionnaires rejected 13 9
Number of samples analyzed 186 186
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Table 2. Demographic characteristics of the prostate cancer patients and their spouses 6 months
after diagnosis (patients [n = 186], spouses [n = 186])
Patients Spouses
Variable n (%) n (%)
6 mo
Age (y), mean (SD) 68.0 (8.1) 65.1 (8.4)
Duration of marital relationship (y)
Mean (SD) 36.2 (15.6)
Basic education
Elementary school/civic school
Comprehensive school/lower
Secondary school
Upper secondary school
112
44
30
60
24
16
86
49
51
46
26
28
Vocational qualifications
Initial vocational qualification
Further vocational qualification
Polytechnic/university degree
No vocational qualification
Missing
58
46
22
56
4
31
25
12
30
2
62
53
28
42
33
29
15
23
Employment status
Working
Not working
63
122
34
66
70
115
38
62
Chronic diseases
25	
	
Yes
No
131
55
70
30
123
63
66
34
Treatment method
Surgery
Radiation therapy
Hormonal treatment
Non-invasive care
64
51
24
45
35
28
13
24
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Table 3. Changes in patients’ (n = 186) and their spouses’ (n = 186) health-related quality of life (RAND-36)
Quality of life dimension At the time of
diagnosis
(baseline)
After 6
months
(follow-up)
Change p value for
the
difference
between the
baseline and
follow-up²
HRQoL
increased
by ≥10
points
HRQoL
decreased
by ≥10
points
M¹ SD M¹ SD M SD   n %  n %
Physical functioning Patients
Spouses
82.1
80.1
19.6
19.4
80.6
78.8
20.9
21.2
-1.5
-1.3
12.6
10.3
0.052
0.105
25
40
14
22
37
27
20
15
Role functioning/physical Patients
Spouses
66.0
69.9
40.1
37.8
62.9
67.4
40.9
40.0
-3.2
-2.5
37.3
32.6
0.186
0.312
37
34
20
19
45
42
25
23
Role functioning/emotional Patients
Spouses
72.4
75.3
37.1
35.1
71.2
76.6
38.0
34.8
-0.8
2.0
42.2
35.4
0.881
0.462
42
40
23
22
45
36
24
20
28	
	
Energy Patients
Spouses
68.9
68.2
20.1
19.3
67.2
68.5
20.2
19.1
-1.6
0.3
15.3
14.5
0.136
0.957
44
42
24
23
63
45
34
24
Emotional well-being Patients
Spouses
77.4
76.8
15.1
14.9
78.3
78.0
15.2
16.0
0.9
1.3
14.3
13.5
0.569
0.319
44
38
24
20
43
26
23
14
Social functioning Patients
Spouses
83.5
85.4
21.5
18.5
81.9
85.5
20.7
20.0
-1.6
0.1
20.5
16.3
0.205
0.860
49
51
26
27
65
48
35
26
Bodily pain Patients
Spouses
76.3
75.1
22.2
23.4
76.6
73.4
23.6
24.1
1.8
-1.8
31.0
18.9
0.859
0.434
77
68
42
37
65
54
35
29
General health Patients
Spouses
59.8
62.5
17.9
17.6
57.7
61.5
19.1
18.8
-2.0
-1.0
13.8
11.8
0.071
0.129
39
41
21
22
57
58
31
31
¹Scale: 0: poor health and quality of life, 100: good health and quality of life
²Wilcoxon signed-rank test
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Table 4. Factors (n = 186) associated with the changes in health-related quality of life according to the linear regression model with the enter
method
Variable
Physical
functioning
Role
functioning/physical
Role
functioning/
emotional
Energy Emotional
well-being
Social
functioning
Bodily pain General
health
p-
value
R² p-value R² p-
value
R² p-
value
R² p-
value
R² p-
value
R² p-
value
R² p-
value
R²
Background
variables¹
0.103 0.095 0.172 0.085 0.336 0.069 0.887 0.033 0.815 0.039 0.839 0.037 0.012 0.131 0.589 0.053
Basic
Education
0.007 0.040 0.081 0.027 0.819 0.002 0.668 0.004 0.983 0.004 0.321 0.012 0.083 0.027 0.682 0.004
Significant p-value for R² (p < 0.05)
¹Age, basic education, vocational qualifications, employment status, chronic diseases, treatment method
